Dec 04, 2018
1:40
For every 40 shares held, investors received 1. The price per share adjusted from $0.01 to $0.00.
The split itself did not change the total investment value.
BioELife Corp. (LITH) trades on the Other OTC in the Drug Manufacturers - Specialty & Generic industry.
BioELife Corp. company overviewThe latest split shown was on December 4, 2018. It was a 1-for-40 reverse split, so shareholders received 1 share for every 40 they held.
This history records one reverse split, on December 4, 2018.